[literature update] H2RA better than PPI for SUP, and I feel like my Sux vs. Roc stance is validated

I review almost two dozen journals every week so you don’t have to! Every Monday I will provide a members-only curated digest of new critical care pharmacy literature.  This week’s 7 articles cover:

1. Interesting how many patients were eventually diagnosed with a “septic shock mimicker”

2. Consider using drug shortage management principles to mitigate the impact of sudden price increases

3. No association between the dose of caloric intake in adult critically ill patients and hospital mortality

4. Yawn….Sux vs Roc…there was no difference between the 2 drugs in terms of clinically acceptable intubating conditions

5. Providing stress ulcer prophylaxis with H2RA therapy may reduce costs, increase survival, and avoid complications compared with PPI therapy

6. Vancomycin + piperacillin-tazobactam was associated with increased risk of AKI compared to vancomycin ± β-lactam

7. It was in rats, but they found the type of lipid used in lipid rescue matters

If you are a founding Beta Program member please log in here:

Username or Email Address

Password

Remember Me

Or

Connect With

Lost Password? Click here to have it emailed to you.